Cargando…

Quantification of Differential Metabolites in Dried Blood Spots Using Second-Tier Testing for SCADD/IBDD Disorders Based on Large-Scale Newborn Screening in a Chinese Population

Background: Although newborn screening (NBS) for metabolic defects using the marker butyl carnitine (C4) combined with the C4-to-acetylcarnitine ratio is adequate, the incorporation of novel parameters may improve differential testing for these disorders without compromising sensitivity. Methods: An...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Wei, Cai, Heng, Li, Huizhong, Ji, Zhe, Gu, Maosheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639864/ https://www.ncbi.nlm.nih.gov/pubmed/34869113 http://dx.doi.org/10.3389/fped.2021.757424

Ejemplares similares

Biochemical, Molecular, and Clinical Characterization of Patients With Primary Carnitine Deficiency via Large-Scale Newborn Screening in Xuzhou Area
por: Zhou, Wei, et al.
Publicado: (2019)

A case report of short-chain acyl-CoA dehydrogenase deficiency (SCADD)
por: Lampret, Barbka Repic, et al.
Publicado: (2015)

Direct Derivatization in Dried Blood Spots for Oxidized and Reduced Glutathione Quantification in Newborns
por: Ten-Doménech, Isabel, et al.
Publicado: (2022)

The second-tier status of fragile X syndrome testing for unexplained intellectual disability/global developmental delay in the era of next-generation sequencing
por: Zhang, Wen, et al.
Publicado: (2022)

Newborn Screening for Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase and Mitochondrial Trifunctional Protein Deficiencies Using Acylcarnitines Measurement in Dried Blood Spots—A Systematic Review of Test Accuracy
por: Stinton, Chris, et al.
Publicado: (2021)

Importance of Second-Look Surgery in a Newborn Presenting With Early Malrotation
por: Kulkarni, Varun, et al.
Publicado: (2022)

Measurement of MMP-7 in micro-volume peripheral blood: development of dried blood spot approach
por: Jiang, Jingying, et al.
Publicado: (2023)

Combining newborn metabolic and DNA analysis for second-tier testing of methylmalonic acidemia
por: Peng, Gang, et al.
Publicado: (2018)

At-home dried blood spot (DBS) collection to increase population heterogeneity representation in pediatric research: An ECHO study
por: Green, Joseph M., et al.
Publicado: (2023)

Implementation of Second-Tier Tests in Newborn Screening for Lysosomal Disorders in North Eastern Italy
por: Burlina, Alberto B., et al.
Publicado: (2019)

Second Tier Molecular Genetic Testing in Newborn Screening for Pompe Disease: Landscape and Challenges
por: Smith, Laurie D., et al.
Publicado: (2020)

Increased detection of primary carnitine deficiency through second-tier newborn genetic screening
por: Lin, Yiming, et al.
Publicado: (2021)

Fragile X protein in newborn dried blood spots
por: Adayev, Tatyana, et al.
Publicado: (2014)

Simultaneous determination of 3-hydroxypropionic acid, methylmalonic acid and methylcitric acid in dried blood spots: Second-tier LC-MS/MS assay for newborn screening of propionic acidemia, methylmalonic acidemias and combined remethylation disorders
por: Monostori, Péter, et al.
Publicado: (2017)

Outcome of Very Premature Newborn Receiving an Early Second Dose of Surfactant for Persistent Respiratory Distress Syndrome
por: Greiner, Eva, et al.
Publicado: (2021)

The Use of Dried Blood Spots for the Quantification of Antihypertensive Drugs
por: Chernonosov, Alexander
Publicado: (2018)

Newborn screening for citrin deficiency and carnitine uptake defect using second-tier molecular tests
por: Wang, Li-Yun, et al.
Publicado: (2013)

Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I
por: Peck, Dawn S., et al.
Publicado: (2020)

Applicability of vancomycin, meropenem, and linezolid in capillary microsamples vs. dried blood spots: A pilot study for microsampling in critically ill children
por: Xiaoyong, Xu, et al.
Publicado: (2023)

Quantification of Zonisamide in Dried Blood Spots and Dried Plasma Spots by UPLC–MS/MS: Application to Clinical Practice
por: Rmandić, Milena, et al.
Publicado: (2022)

Newborn Dried Blood Spots for Serologic Surveys of COVID-19
por: Liu, Feimei, et al.
Publicado: (2020)

Analysis of Cannabinoids and Metabolites in Dried Urine Spots (DUS)
por: Moretti, Matteo, et al.
Publicado: (2021)

Stability of Cocaine, Opiates, and Metabolites in Dried Saliva Spots
por: Almeida, Ema, et al.
Publicado: (2022)

Influence of Hematocrit and Total-Spot Volume on Performance Characteristics of Dried Blood Spots for Newborn Screening
por: Hall, Elizabeth M., et al.
Publicado: (2015)

Evaluation of Multiple Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis-I
por: Herbst, Zackary M., et al.
Publicado: (2020)

The Use of Alcohol versus Dry Care for the Umbilical Cord in Newborns: A Systematic Review and Meta-analysis of Randomized and Non-randomized Studies
por: Al-Shehri, Hassan
Publicado: (2019)

Development of Second-Tier Liquid Chromatography-Tandem Mass Spectrometry Analysis for Expanded Newborn Screening in Japan
por: Shigematsu, Yosuke, et al.
Publicado: (2021)

Newborn Screening for Methylmalonic Acidemia in a Chinese Population: Molecular Genetic Confirmation and Genotype Phenotype Correlations
por: Zhou, Wei, et al.
Publicado: (2019)

Vertical Transfer of Metabolites Detectable from Newborn’s Dried Blood Spot Samples Using UPLC-MS: A Chemometric Study
por: Olarini, Alessandra, et al.
Publicado: (2022)

Application of a diagnostic methodology by quantification of 26:0 lysophosphatidylcholine in dried blood spots for Japanese newborn screening of X-linked adrenoleukodystrophy
por: Wu, Chen, et al.
Publicado: (2017)

Evaluation of Two Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis Type II
por: Herbst, Zackary M., et al.
Publicado: (2022)

Quantification of 6-Mercaptopurine and Its Metabolites in Patients with Acute Lympoblastic Leukemia Using Dried Blood Spots and UPLC-MS/MS
por: Supandi, Supandi, et al.
Publicado: (2018)

Implementation of second-tier tests in newborn screening for the detection of vitamin B(12) related acquired and genetic disorders: results on 258,637 newborns
por: Pajares, Sonia, et al.
Publicado: (2021)

The Value of Very Good “Second Tier” Journals
por: King, Spencer B.
Publicado: (2020)

Correction to: implementation of second-tier tests in newborn screening for the detection of vitamin B12 related acquired and genetic disorders: results on 258,637 newborns
por: Pajares, Sonia, et al.
Publicado: (2023)

The prognostic value of multivoxel magnetic resonance spectroscopy determined metabolite levels in white and grey matter brain tissue for adverse outcome in term newborns following perinatal asphyxia
por: van Doormaal, Pieter Jan, et al.
Publicado: (2011)

Performance of Expanded Newborn Screening in Norway Supported by Post-Analytical Bioinformatics Tools and Rapid Second-Tier DNA Analyses
por: Tangeraas, Trine, et al.
Publicado: (2020)

Cystic Fibrosis Newborn Screening in Austria Using PAP and the Numeric Product of PAP and IRT Concentrations as Second-Tier Parameters
por: Zeyda, Maximilian, et al.
Publicado: (2021)

Individualized Hemodynamic Management in Newborns
por: de Boode, Willem P.
Publicado: (2020)

Validation of a Fast, Robust, Inexpensive, Two-Tiered Neonatal Screening Test algorithm on Dried Blood Spots for Spinal Muscular Atrophy
por: Strunk, Annuska, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t0amf5ls17cjc1h3ejjs5nvstf